Precision Toxicology, LLC

Precision Toxicology, LLC was paid $213.77M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 27% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#4 of 561

Median peer was paid$222K

This provider vs. median963×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	818,733	$23.76M
2019	1,305,850	$31.95M
2020	1,219,527	$26.06M
2021	668,949	$25.82M
2022	627,158	$36.40M
2023	581,691	$39.02M
2024incomplete	423,959	$30.77M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	27%	508,629	270,312	$58.03M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	22%	583,763	338,389	$47.84M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	16%	914,453	453,379	$33.22M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	15%	356,856	192,307	$31.86M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	6.4%	254,069	145,428	$13.61M
80321		<1%	124,755	92,634	$1.87M
80361		<1%	157,854	107,983	$1.55M
80348		<1%	161,764	110,928	$1.52M
80346		<1%	146,894	107,286	$1.52M
80356		<1%	148,641	104,327	$1.48M
80365		<1%	155,350	105,983	$1.47M
80354		<1%	152,309	107,088	$1.45M

36 more codes

80353		<1%	158,772	$1.43M
80373		<1%	132,342	$1.37M
80358		<1%	140,287	$1.35M
80349		<1%	140,350	$1.30M
80360		<1%	118,944	$1.16M
80323		<1%	108,625	$1.08M
80355		<1%	112,259	$1.05M
80359		<1%	114,947	$1.00M
80362		<1%	86,634	$983K
80325		<1%	99,171	$917K
80375		<1%	104,358	$902K
80372		<1%	83,513	$768K
80324		<1%	63,398	$744K
80371		<1%	79,739	$651K
80366		<1%	67,692	$648K
80367		<1%	62,929	$498K
80363		<1%	51,030	$486K
80369		<1%	41,614	$404K
80357		<1%	35,468	$329K
80368		<1%	35,752	$303K
80338		<1%	28,620	$214K
80374		<1%	16,906	$182K
80345		<1%	30,844	$121K
80343		<1%	8,092	$108K
80336		<1%	17,947	$106K
80333		<1%	13,505	$75K
80342		<1%	11,508	$67K
84702		<1%	3,731	$59K
84311		<1%	2,731	$9K
82570		<1%	2,732	$6K
83986		<1%	2,730	$4K
81003		<1%	2,726	$3K
80335		<1%	457	$2K
80350		<1%	112	$1K
80332		<1%	43	$116.72
G0479	Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service	0%	22	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGALLEGO, MIGUEL (CEO)

Same official

Other billing entities under GALLEGO, MIGUEL

Full network →

Provider	Location	Paid
Precision Toxicology, LLC	Dartmouth, MA	$3.19M
Precision Toxicology, LLC	West Hartford, CT	$2.93M
Precision Toxicology, LLC	Marquette, MI	$758K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.